Translational Health Science and Technology Institute (thsti) Job Notification: Translational Health Science and Technology Institute (thsti) has invited applications for the Junior Research fellow/Project Associate-I post. Interested persons can apply for thsti Recruitment 2020 through the prescribed format on or before 12 May 2020.
THSTI is a part of the interdisciplinary Bio tech. Sci. Cluster at Faridabad, Haryana in the NCR. The Translational Health Science and Technology Institute (thsti) is designed to be a dynamic enter. with a mission to conduct innov. transitional research and to develop research collab. across disciplines and prof. to translate concepts into prod. to improve human health.
Important Date:
- Last Date for submission of application for JRF/Project Associate Post: 12 May 2020
- Interview of through video conferencing: 18 May 2020
Translational Health Science and Technology Institute (thsti) Junior Research fellow/Project Associate-I Vacancy Details
- Junior Research fellow/Project Associate-I: 01 Post
Eligibility Criteria for Junior Research fellow/Project Associate-I Job
Educational Qualification:
Persons selected through National Eligibility Test (NET) (for Junior Research Fellow JRF) as mentioned the DST office or Non National Eligibility Test (NET) qualify persons (for Project Associate) as mentioned in the DST office or equivalent from a recognized university/institute with a minimum 55% marks.
| Official Notification Download Here | |
| Official Website Link |
Download our Sarkari Naukri app from Play Store
How to Apply
Interested persons can apply for thsti Recruitment 2020 through the prescribed format on or before 12 May 2020. Interested persons fulfilling the criteria as mentioned above may send their resume to info@thsti.res.in on before 12 May 2020 duly mentioning the name of the post in the subject for which they want to appear for the interview. The interview will be through video conferencing on 18 May 2020. Shortlisted persons will be sent email for attending the interview.
Comments
All Comments (0)
Join the conversation